TTNP

Titan Pharmaceuticals News

Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
$80.29
Small Cap Basic
Monthly Subscription
for only
$33.03
Big Cap Pro
Monthly Subscription
for only
$52.04
VAT not included
Company Name Stock Ticker Symbol Market Type
Titan Pharmaceuticals Inc TTNP NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.0602 -1.91% 3.0998 14:59:54
Open Price Low Price High Price Close Price Prev Close
3.16 3.01 3.1679 3.16
more quote information »

Recent News

Date Time Source Heading
1/19/202106:22EDGARCurrent Report Filing (8-k)
1/19/202106:12EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
1/15/202109:15PRNUSTitan Pharmaceuticals Announces Pricing of $9.7 Million..
1/08/202116:16EDGARCurrent Report Filing (8-k)
1/07/202110:01EDGARAmended Statement of Ownership (sc 13g/a)
12/31/202006:01EDGARCurrent Report Filing (8-k)
12/31/202006:01EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
12/17/202006:02EDGARCurrent Report Filing (8-k)
12/16/202008:00PRNUSTitan Pharmaceuticals Regains Compliance with Nasdaq Listing..
12/16/202006:04EDGARNotice of Effectiveness (effect)
12/08/202006:02EDGARSecurities Registration Statement (s-1)
12/03/202016:24EDGARCurrent Report Filing (8-k)
12/02/202016:59EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
11/30/202012:50PRNUSTitan Pharmaceuticals Announces Reverse Stock Split
11/25/202008:29EDGARProxy Statement (definitive) (def 14a)
11/16/202008:45PRNUSTitan Pharmaceuticals Reports Third Quarter 2020 Financial..
11/09/202014:32EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
11/09/202006:06EDGARStatement of Ownership (sc 13g)
11/02/202016:14EDGARCurrent Report Filing (8-k)
11/02/202016:08EDGARProxy Statement (definitive) (def 14a)
11/02/202008:00PRNUSTitan Pharmaceuticals Completes Debt Settlement With Molteni..
10/29/202017:01EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
10/29/202006:06EDGARNotice of Effectiveness (effect)
10/28/202016:47EDGARCurrent Report Filing (8-k)
10/28/202015:00PRNUSTitan Pharmaceuticals Announces Pricing of $8.0 Million..
10/28/202008:00PRNUSTitan Pharmaceuticals Enters Into Definitive Agreement To..
10/27/202016:12EDGARSecurities Registration Statement (s-1/a)
10/26/202006:41EDGARSecurities Registration Statement (s-1/a)
10/26/202006:36EDGARCurrent Report Filing (8-k)
10/26/202006:30PRNUSTitan Pharmaceuticals Announces Debt Settlement Agreement..
10/23/202017:08EDGARProxy Statement - Notice of Shareholders Meeting..
10/15/202015:56EDGARCurrent Report Filing (8-k)
10/15/202008:00PRNUSTitan Pharmaceuticals Provides a Strategic & Corporate..
10/01/202016:42EDGARStatement of Ownership (sc 13g)
9/25/202006:14EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
9/25/202006:01EDGARCurrent Report Filing (8-k)
9/24/202009:00PRNUSTitan Pharmaceuticals Announces Pricing of $2.7 Million..
9/18/202016:45PRNUSTitan Pharmaceuticals' Stockholders Approve Proposal To..
9/18/202016:28EDGARCurrent Report Filing (8-k)
9/15/202008:30PRNUSTitan's Probuphine® Commercialization Partner, Molteni,..
9/14/202016:57EDGARCurrent Report Filing (8-k)
9/14/202016:55EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
9/14/202008:30PRNUSTitan Pharmaceuticals Provides Update To Stockholders On..
9/01/202006:04EDGARCurrent Report Filing (8-k)
9/01/202006:04EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
8/20/202006:01EDGARCurrent Report Filing (8-k)
8/14/202008:46EDGARQuarterly Report (10-q)
8/14/202008:45PRNUSTitan Pharmaceuticals Reports Second Quarter 2020 Financial..
8/13/202006:09EDGARAmended Current Report Filing (8-k/a)
8/13/202006:07EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
See more news about this stock »
Your Recent History
NASDAQ
TTNP
Titan Phar..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210120 20:15:05